EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Pharmacotherapeutic strategies for drug-resistant epilepsy in children

Stéphane Auvin, Nicola Specchio

Epilepsy & Behavior · 2024-12 · 161 · 110139

DOI: 10.1016/j.yebeh.2024.110139 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Epilepsy & Behavior, 2024-12. Verfasst von Stéphane Auvin und 1 weiteren Autor:innen. Beteiligte Einrichtung: APHP, Robert Debré University Hospital, Pediatric Neurology Department, CRMR epilepsies rares, EpiCare member, Paris, France; Université Paris Cité, …. Hauptthemen laut MEDLINE: Drug Resistant Epilepsy, Anticonvulsants. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 93 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug resistance is defined as the failure of adequate trials of two tolerated and appropriately chosen antiseizure medications to achieve sustained seizure freedom. In case of uncontrolled seizures, pseudo-drug-resistance (poor compliance, a worsening effect of an antiseizure medication, a diagnosis of psychogenic non-epileptic seizure) should be first ruled out in case of pediatric epilepsies. This paper discusses the process of choosing antiseizure medication and the concepts of rationale polytherapy and precision medicine. In drug-resistant epilepsy, when curative surgery is not feasible, the aim of the treatment is focused on the improvement of quality of life rather than on seizure count. In recent years, despite an increase in available antiseizure medications, the incidence of drug-resistant epilepsy has not changed. Precision medicine may offer in rare epilepsies a mechanism-driven treatment, but it is still unclear if this will end up in an improvement of efficacy in drug-resistant epilepsies. Gene therapy with antisense oligonucleotides or Adeno-associated Virus (AAV) is transitioning from the experimental side to the first human trial. It may modify the natural history of selected epileptic syndromes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistant EpilepsyAnticonvulsantsHumansChild

Stichwörter der Autor:innen

Antiepileptic drugsAntiseizure medicationDrug resistance epilepsyEpilepsySyndromes

Substanzen

Anticonvulsants

Autor:innen und Institutionen

  • APHP, Robert Debré University Hospital, Pediatric Neurology Department, CRMR epilepsies rares, EpiCare member, Paris, France; Université Paris Cité, INSERM NeuroDiderot, Paris, France; Institut Universitaire de France,…
  • Neurology, Epilepsy and Movement Disorders Unit, Bambino Gesu' Children's Hospital, IRCCS, Full Member of European Reference Network on Rare and complex Epilepsies EpiCARE, Rome, Italy; University Hospitals KU Leuven, B…

Zitieren

APA

Auvin, S., & Specchio, N. (2024). Pharmacotherapeutic strategies for drug-resistant epilepsy in children. Epilepsy & Behavior, 161, 110139. https://doi.org/10.1016/j.yebeh.2024.110139

Vancouver

Auvin S, Specchio N. Pharmacotherapeutic strategies for drug-resistant epilepsy in children. Epilepsy & Behavior. 2024;161:110139. doi:10.1016/j.yebeh.2024.110139

BibTeX
@article{Auvin2024,
  author = {Auvin, Stéphane and Specchio, Nicola},
  title = {Pharmacotherapeutic strategies for drug-resistant epilepsy in children},
  journal = {Epilepsy & Behavior},
  year = {2024},
  volume = {161},
  pages = {110139},
  doi = {10.1016/j.yebeh.2024.110139}
}
Kostenlos starten →